These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 37955686)

  • 41. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
    Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
    Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
    Lin J; Lin Y; Huang Z; Li X
    Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
    Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
    Front Immunol; 2022; 13():967277. PubMed ID: 36466837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic and immune-related value of STK17B in skin cutaneous melanoma.
    Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J
    PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment.
    Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B
    Front Genet; 2022; 13():917007. PubMed ID: 35899194
    [No Abstract]   [Full Text] [Related]  

  • 48. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
    Yan K; Wang Y; Lu Y; Yan Z
    J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma.
    Cen X; Li M; Yao A; Zheng Y; Lai W
    J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma.
    Zhang W; Wang S
    Melanoma Res; 2024 Jun; 34(3):215-224. PubMed ID: 38364052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.
    Li H; Sun X; Zhao Y; Zhang C; Jiang K; Ren J; Xing L; He M
    BMC Cancer; 2023 Jun; 23(1):528. PubMed ID: 37296415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutrophil extracellular trap related risk score exhibits crucial prognostic value in skin cutaneous melanoma, associating with distinct immune characteristics.
    Zhang H; Bi X; Yan P; Wang C
    Skin Res Technol; 2024 Aug; 30(8):e70008. PubMed ID: 39167030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
    Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
    Front Immunol; 2022; 13():919145. PubMed ID: 36211371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients.
    Zhang X; Ding C; Zhao Z
    Adv Med Sci; 2022 Sep; 67(2):364-378. PubMed ID: 36155341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.
    Xu M; Ma X; Wang Y; Yu Z; Zheng X; Dai H; Xue C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):313. PubMed ID: 38900244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 59. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
    Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
    Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.